vTv Therapeutics Inc. (NASDAQ:VTVT) Financings

vTv Therapeutics Inc.

Financings

RaiseDate
Private placement of units of Class A common stock or pre-funded warrants with accompanying warrants
Announced: US$80M · US$15.265 a unit · Warrants at US$22.71 · TD Cowen +1
Dealers: TD Cowen (co-lead), Evercore ISI (co-lead)
Buyers: Samsara BioCapital, L.P. (existing investor); T1D Fund (existing investor); Trails Edge Capital Partners (new investor); Invus (new investor)
Use of proceeds: Fund the ongoing CATT1 Phase 3 trial and continued development of cadisegliatin for type 1 diabetes
Sep 2, 2025

Read by 6ix AI from the company's releases